CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy

Gunnar M. Buyse, Nathalie Goemans, Erik Henricson, Alejandro Jara, Marleen van den Hauwe, Robert Leshner, Julaine M. Florence, Jill E. Mayhew, Diana M. Escolar

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

The authors report a pilot open-label two-center therapeutic trial of oxatomide in 14 steroid-naive DMD boys aged 5-10 years. Comparison of linear evolutions between 3 months medication-free lead-in periods and 6 months treatment periods showed no significant differences in quantitative (QMT) and manual (MMT) measurements of muscle strength and timed functional tests. A modest mitigation of strength deterioration over time cannot be excluded.

Original languageEnglish
Pages (from-to)337-340
Number of pages4
JournalEuropean Journal of Paediatric Neurology
Volume11
Issue number6
DOIs
StatePublished - Nov 1 2007

Keywords

  • Clinical trial
  • Duchenne
  • Muscle
  • Muscular dystrophy
  • Oxatomide
  • Treatment

Fingerprint Dive into the research topics of 'CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy'. Together they form a unique fingerprint.

  • Cite this

    Buyse, G. M., Goemans, N., Henricson, E., Jara, A., van den Hauwe, M., Leshner, R., Florence, J. M., Mayhew, J. E., & Escolar, D. M. (2007). CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy. European Journal of Paediatric Neurology, 11(6), 337-340. https://doi.org/10.1016/j.ejpn.2007.02.009